Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · IEX Real-Time Price · USD
4.080
-0.130 (-3.09%)
At close: Apr 25, 2024, 4:00 PM
4.290
+0.210 (5.15%)
After-hours: Apr 25, 2024, 7:59 PM EDT

Autolus Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Cash & Equivalents
240.34382.76310.68154.09211.43189.3102.3228.06
Cash & Cash Equivalents
240.34382.76310.68154.09211.43189.3102.3228.06
Cash Growth
-37.21%23.20%101.63%-27.12%11.69%85.01%264.66%-
Receivables
000009.854.440
Other Current Assets
34.9743.0136.2842.937.83002.87
Total Current Assets
275.3425.77346.95196.98249.26199.14106.7630.93
Property, Plant & Equipment
95.6558.4252.3289.6851.579.223.33.25
Long-Term Investments
0.981.832.042.632.04000
Goodwill and Intangibles
000.070.160.259.37.30
Other Long-Term Assets
3.444.254.194.790.41000
Total Long-Term Assets
100.0864.558.6197.2554.2818.5110.63.25
Total Assets
375.38490.27405.56294.24303.53217.66117.3634.18
Accounts Payable
0.460.650.562.261.08-12.52-3.622.01
Current Debt
5.055.044.453.592.51000
Other Current Liabilities
39.2240.6823.5427.7821.429.668.650.73
Total Current Liabilities
44.7446.3728.5533.6324.9817.145.032.74
Long-Term Debt
218.81145.1263.5650.5723.71000.19
Other Long-Term Liabilities
0.360.120.13000.61.030.57
Total Long-Term Liabilities
219.17145.2363.6950.5723.710.61.030.76
Total Liabilities
263.91191.692.2484.2148.6912.523.623.49
Total Debt
223.87150.1668.0154.1626.22000.19
Debt Growth
49.09%120.77%25.58%106.56%----
Retained Earnings
-878.56-670.18-521.34-379.24-237.15163.84-27.19-28.18
Comprehensive Income
-28.99-38.9-8.57-5.86-8.6900-4.65
Shareholders' Equity
111.47298.67313.32210.03254.84205.14113.7430.69
Net Cash / Debt
16.47232.61242.6699.92185.21189.3102.3227.87
Net Cash / Debt Growth
-92.92%-4.14%142.85%-46.05%-2.16%85.01%267.12%-
Net Cash Per Share
0.092.453.371.944.306.007.422.81
Working Capital
230.57379.41318.4163.35224.27182101.7328.19
Book Value Per Share
0.643.144.354.075.926.508.253.09
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).